Testosterone Lawsuit Update: Bellwether Case Selection Process Being Disputed in AndroGel MDL

August 31, 2015

Banville Law reports on an update in the pending testosterone litigation involving AbbVie, Auxilium, Pfizer and other pharmaceutical companies.

Nearly 2,000 lawsuits have been filed in relation to allegedly dangerous side effects of testosterone replacement therapy (TRT) supplements since the Multidistrict Litigation (MDL) was established in the US District Court for the Northern District of Illinois.

The first bellwether trial is scheduled to begin on October 1st, 2016 and several other trials are scheduled to commence shortly thereafter. However, while the dates of the initial trials have been set, the specific cases that will be tried have not been chosen yet.

Parties from both sides of the litigation discussed the selection process for the bellwether cases in a recent status meeting held on August 14th. According to official minutes from the status conference, defendant AbbVie (maker of AndroGel) proposed that the court select 32 cases for discovery. After the discovery process is complete, AbbVie proposes that plaintiffs and defendants then agree on six cases (from the pool of 32) to go to trial.

Conversely, plaintiffs proposed that both sides of the litigation submit a list of 16 potential cases for selection and that the court choose six cases for the bellwether trials.

Low T Litigation: The Importance of Bellwether Trial Selection

“The selection of bellwether trials will be a key part of this litigation,” commented Laurence Banville, Esq. of Banville Law.

“The outcomes of these initial trials will set the pace for the remainder of the MDL and will help parties on both sides of the litigation to make crucial decisions going forward,” continued Banville.

Banville is a sponsor of online resource center LowTestosteroneCase.com, which provides information on the testosterone litigation, as well as access to legal representation for those wishing to file a complaint.

Please direct all questions about this press release and about pending testosterone litigation to Laurence Banville, Esq. at 888-478-9711.

Additional News Releases From Banville Law

About Banville Law

Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.

Contact Banville Law

Laurence Banville, Esq.

165 West End Avenue, #1H
New York, NY 10023
United States (US)

888-997-3792

info@banvillelaw.com

Visit Website

Social Media

📈 See How Agencies Grow with Press Releases

Download the case study that shows what’s working now in visibility + SEO.

    We won't send you spam. Unsubscribe at any time.

    🕒 Write Press Releases That Get Picked Up

    Use our step-by-step blueprint to land traffic, links, and attention in 10 minutes.

      We won't send you spam. Unsubscribe at any time.

      Scale Press Release. Win More Clients.

      Grab our proven toolkit to land coverage and retain high-value clients—fast.

        We won't send you spam. Unsubscribe at any time.

        Presentation Video

        Book a Demo

        Want to see how it all works? Schedule a quick demo and we'll walk you through how to get more visibility, backlinks, and results.

          We respect your privacy. Unsubscribe at any time.